First RNA therapy success: man with rare ALS improves after mutation-targeting treatment

burny_tech · x · 2026-09-21

Nature reports that a man with a rare mutation-driven form of motor neuron disease (ALS) became the first person to receive an antisense oligonucleotide therapy targeting his specific genetic mutation. A year later his symptoms improved and he continues working as a physician. Unlike conventional gene therapy, the RNA-based drug acts on the disease-causing transcript. Researchers call the early results exciting, laying groundwork for treating other rare-mutation neurodegenerative diseases.

Original post →

More from Research

• Researchers formally verify the Kubernetes control plane with a compositional CORE spec — tianyin_xu · 2026-09-21
• Astra shows any 3D/4D prior can be distilled into VLMs, a new embodied AI paradigm — mariyaivasileva · 2026-09-21
• ReCouPLe: Reason-Augmented Preference Learning Boosts Reward Accuracy 1.5x Under Shift — burny_tech · 2026-09-21
• kalomaze rethinks 'cribbing SSL backbone features' after peers hit multimodal walls — kalomaze · 2026-09-21
• Closed-loop spatial understanding from just two wrist cameras, no gripper feedback — ChongZzZhang · 2026-09-21
• DeepMind's weather model ingests raw satellite radiances hourly, ending the 6-12h analysis lag — burny_tech · 2026-09-21

Research channel →